Abstract

APARICIO-HERNANDEZ, R; GARCIA-LUQUE, A; ACUNA-VEGA, A  and  GRANDA-LOBATO, P. Positive assessment of drugs: October 2020. Sanid. Mil. [online]. 2021, vol.77, n.1, pp.29-34.  Epub June 07, 2021. ISSN 1887-8571.  https://dx.doi.org/10.4321/s1887-85712021000100005.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in October of 2019, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Keywords : Cabotegravir (Vocabria®); Células CD3+ autólogas transducidas anti CD-19 (Tecartus®); Cultivo celular autólogo de CD34+, enriquecido con células madre y células progenitoras hematopoyéticas transducidas ex vivo usando un vector lentiviral (lentivirus) con el gen humano arilsulfatasa A (Libmeldy®); Fenfluramina (Fintepla®); Formoterol 5 µG/9 µG Bromuro de glicopirronio/160 µG Budesonida (Trixeo Aerosphere®); Inclisirán (Leqvio®); Lumasiran (Oxlumo®); Polvo desengrasado de arachis hypogaea l. (semilla de cacahuete) (Palforzia®); Rilpivirina (Rekambys®).

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )